Cross-fund · 5 holders
LXEO
LEXEO THERAPEUTICS INC
CUSIP 52886X107
5
Tracked holders
$109.0M
Aggregate value
16,144,109
Shares
5
Active funds
Funds holding LXEO
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $38.7M | — | +1,668,020 | +74.9% |
| BlackRock | Institutional | Q1 2026 | $29.3M | — | +203,308 | +4.1% |
| Citadel | Multi-Strategy | Q1 2026 | $22.1M | — | +71,382 | +1.9% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $9.6M | 0.01% | -214,273 | -11.3% |
| Millennium | Multi-Strategy | Q1 2026 | $9.3M | — | +704,756 | +77.6% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.